The RCPCH care pathway for children with drug allergies: an evidence and consensus based national approach
The RCPCH care pathway for children with drug allergies: an evidence and consensus based national approach
Aims The Royal College of Paediatrics and Child Health (RCPCH) was commissioned by the Department of Health to develop a drug allergy pathway. It focuses on defining the competences to improve the equity of care received by children.
Method The drug pathway was developed by a multidisciplinary working group and was based on a comprehensive review of evidence. The team decided to focus on IgE-mediated reactions as these have the greatest potential to be life-threatening.
Results The results are presented in four parts: evidence review, pathway mapping, external review and core knowledge documents. The evidence review found a high percentage of putative penicillin allergy is not confirmed by objective testing and that resensitisation to ?-lactam drugs was infrequent. It also highlighted the importance of a detailed history and accurate diagnosis along with clear communication of test results to both family and primary care.
Conclusions This pathway demonstrates the spectrum of drug allergy is varied and may differ for young children compared with older children and adults. The authors highlight the paucity of evidence to support allergy testing for most drugs, in children, other than supervised incremental provocation tests (when indicated). Acute presentations require emergency health professionals to address underlying allergic issues, including recognition and avoidance of potential drug allergy triggers. Non-acute presentations may include multi-system symptoms which may have a broad differential diagnosis; this document signposts to the relevant partners in the RCPCH care pathway portfolio. Management combines a care package including a definitive diagnosis, initiating treatments and ongoing education.
i15-i18
du Toit, G.
bd3ee72d-f4fa-4e4f-bf73-f0a0678ca7b0
Lloyd, K.
a1527000-1474-438f-afe3-af7f2ba3c752
Sinnott, L.
a6aa069c-0738-46f2-a2d6-c771e4a68403
Forster, D.
26b31f4f-d384-4f4a-8d72-9d39da3cf146
Austin, M.
f6d67af8-65b4-493a-96e3-0de90c2253c7
Clark, C.
6109b019-09b7-471c-b090-27ea2e528750
Tuthill, D.
f2e67f33-15c3-4c72-8007-b8d522abd5bd
Lucas, J. S.
5cb3546c-87b2-4e59-af48-402076e25313
Brathwaite, N.
d09e7a16-846a-4372-91b4-1c064453a081
Warner, J.
a7bcf9ec-794a-4cc5-8498-7d13d8b5927d
2011
du Toit, G.
bd3ee72d-f4fa-4e4f-bf73-f0a0678ca7b0
Lloyd, K.
a1527000-1474-438f-afe3-af7f2ba3c752
Sinnott, L.
a6aa069c-0738-46f2-a2d6-c771e4a68403
Forster, D.
26b31f4f-d384-4f4a-8d72-9d39da3cf146
Austin, M.
f6d67af8-65b4-493a-96e3-0de90c2253c7
Clark, C.
6109b019-09b7-471c-b090-27ea2e528750
Tuthill, D.
f2e67f33-15c3-4c72-8007-b8d522abd5bd
Lucas, J. S.
5cb3546c-87b2-4e59-af48-402076e25313
Brathwaite, N.
d09e7a16-846a-4372-91b4-1c064453a081
Warner, J.
a7bcf9ec-794a-4cc5-8498-7d13d8b5927d
du Toit, G., Lloyd, K., Sinnott, L., Forster, D., Austin, M., Clark, C., Tuthill, D., Lucas, J. S., Brathwaite, N. and Warner, J.
(2011)
The RCPCH care pathway for children with drug allergies: an evidence and consensus based national approach.
Archives of Disease in Childhood, 96, supplement 2, .
(doi:10.1136/archdischild-2011-300116).
Abstract
Aims The Royal College of Paediatrics and Child Health (RCPCH) was commissioned by the Department of Health to develop a drug allergy pathway. It focuses on defining the competences to improve the equity of care received by children.
Method The drug pathway was developed by a multidisciplinary working group and was based on a comprehensive review of evidence. The team decided to focus on IgE-mediated reactions as these have the greatest potential to be life-threatening.
Results The results are presented in four parts: evidence review, pathway mapping, external review and core knowledge documents. The evidence review found a high percentage of putative penicillin allergy is not confirmed by objective testing and that resensitisation to ?-lactam drugs was infrequent. It also highlighted the importance of a detailed history and accurate diagnosis along with clear communication of test results to both family and primary care.
Conclusions This pathway demonstrates the spectrum of drug allergy is varied and may differ for young children compared with older children and adults. The authors highlight the paucity of evidence to support allergy testing for most drugs, in children, other than supervised incremental provocation tests (when indicated). Acute presentations require emergency health professionals to address underlying allergic issues, including recognition and avoidance of potential drug allergy triggers. Non-acute presentations may include multi-system symptoms which may have a broad differential diagnosis; this document signposts to the relevant partners in the RCPCH care pathway portfolio. Management combines a care package including a definitive diagnosis, initiating treatments and ongoing education.
This record has no associated files available for download.
More information
Published date: 2011
Organisations:
Clinical & Experimental Sciences
Identifiers
Local EPrints ID: 203861
URI: http://eprints.soton.ac.uk/id/eprint/203861
ISSN: 0003-9888
PURE UUID: 0cd40175-e367-439d-92a1-b6db16582319
Catalogue record
Date deposited: 22 Nov 2011 11:48
Last modified: 15 Mar 2024 03:12
Export record
Altmetrics
Contributors
Author:
G. du Toit
Author:
K. Lloyd
Author:
L. Sinnott
Author:
D. Forster
Author:
M. Austin
Author:
C. Clark
Author:
D. Tuthill
Author:
N. Brathwaite
Author:
J. Warner
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics